Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Circadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucoma.

Quaranta L, Katsanos A, Floriani I, Riva I, Russo A, Konstas AG.

J Clin Pharmacol. 2012 Oct;52(10):1552-7. Epub 2011 Nov 22.

PMID:
22110164
2.

Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.

Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, Gandolfo E.

Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2917-23.

PMID:
16799034
3.
5.

Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.

Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A.

Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2566-73.

PMID:
10937568
8.

Timogel® vs timolol 0.5% ophthalmic solution: efficacy, safety, and acceptance.

Rolle T, Curto D, Alovisi C, Franzone M, Brogliatti B, Grignolo FM.

Eur J Ophthalmol. 2012 Jan-Feb;22(1):28-33. doi: 10.5301/ejo.5000006.

PMID:
22167540
10.

Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.

Stewart WC, Konstas AG, Nelson LA, Kruft B.

Ophthalmology. 2008 Jul;115(7):1117-1122.e1. Epub 2008 Feb 20.

PMID:
18082886
12.

A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.

Eur J Ophthalmol. 2007 Mar-Apr;17(2):183-90.

PMID:
17415690
13.

24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM; Bimatoprost Circadian IOP Study Group.

Surv Ophthalmol. 2004 Mar;49 Suppl 1:S26-35.

PMID:
15016559
14.

Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.

Liu JH, Medeiros FA, Slight JR, Weinreb RN.

Ophthalmology. 2009 Mar;116(3):449-54. doi: 10.1016/j.ophtha.2008.09.054. Epub 2009 Jan 20.

PMID:
19157559
15.

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.

Konstas AG, Stewart WC, Topouzis F, Tersis I, Holmes KT, Stangos NT.

Am J Ophthalmol. 2001 Jun;131(6):729-33.

PMID:
11384568
16.

Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.

Goldberg I, Cunha-Vaz J, Jakobsen JE, Nordmann JP, Trost E, Sullivan EK; International Travoprost Study Group.

J Glaucoma. 2001 Oct;10(5):414-22.

PMID:
11711841
18.

Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.

Quaranta L, Miglior S, Floriani I, Pizzolante T, Konstas AG.

Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4226-31. doi: 10.1167/iovs.08-1744. Epub 2008 May 23.

PMID:
18502991
19.

Comparison of intraocular pressure lowering effect of once daily morning vs evening dosing of latanoprost/timolol maleate combination.

Takmaz T, Aşik S, Kürkçüoğlu P, Gurdal C, Can I.

Eur J Ophthalmol. 2008 Jan-Feb;18(1):60-5.

PMID:
18203086
20.

Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure.

Stewart WC, Leland TM, Cate EA, Stewart JA.

J Glaucoma. 1998 Dec;7(6):402-7.

PMID:
9871862
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk